Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience
Shin Heon Lee, Jung Won Choi, Doo-Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee
J Korean Neurosurg Soc. 2023;66(5):562-572. Published online 2023 Jan 16 DOI: https://doi.org/10.3340/jkns.2022.0229
Citations to this article as recorded by 
Intra-arterial Bevacizumab in Adult Patients With Steroid-Refractory Cerebral Radiation Necrosis: An Observational Study of Clinical Indications and Outcomes
Lisa B Shields, Robert J Kadner, Mahan Ghiassi, Christopher T Shelburne, Michael W Daniels, Shervin R Dashti
Cureus.2025;[Epub] CrossRef
Hemorrhagic and ischemic risks of anti-VEGF therapies in glioblastoma
Ozal Beylerli, Ilgiz Gareev, Andrey Kaprin, Aamir Ahmad, Vladimir Chekhonin, Shanshan Yang, Guang Yang
Cancer Gene Therapy.2025; 32(7): 762. CrossRef
Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastases
Kylie Jung, Sudhir Das Sivadas, Xavier Fitzgerald, Claire Phillips, Nikki Plumridge, Lavinia Spain, Aparna D. Rao, Joseph Sia
Journal of Neuro-Oncology.2025;[Epub] CrossRef
Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy
Teuta Zoto Mustafayev, Menekse Turna, Yasemin Bolukbasi, Evrim Tezcanli, Yildiz Guney, Fazilet Oner Dincbas, Beste Melek Atasoy, Gamze Ugurluer, Hale Basak Caglar, Banu Atalar, Enis Ozyar
BMC Cancer.2024;[Epub] CrossRef
Editors’ Pick in September 2023
Hee-Jin Yang
Journal of Korean Neurosurgical Society.2023; 66(5): 483. CrossRef
Bevacizumab
Reactions Weekly.2023; 1985(1): 115. CrossRef